Successful CFDA Inspection
Capabilities
Pharmaron’s Toxicology and Safety Pharmacology (TSP) site in Beijing passed the CFDA GLP inspection and received the GLP certificate in June 2017.
This is the third CFDA GLP inspection of the TSP site as part of the CFDA GLP re-inspection program. The success of the GLP inspection allows Pharmaron to expand its capacities significantly to accommodate the increasing business volume in the safety assessment area. This includes supporting CFDA IND filings and dual IND filings with CFDA and other international regulatory agencies, such as the US FDA and OECD member agencies. Our TSP site has passed inspections twice by the US FDA, once by EMA and once by the Belgium GLP Bureau.
Learn more about our small molecule services
